These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9535991)

  • 1. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells.
    Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY
    J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG; Zhang F; Jin XL; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
    Li JG; Benovic JL; Liu-Chen LY
    Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
    Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
    Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
    Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists.
    Chen Y; Chen C; Wang Y; Liu-Chen LY
    J Pharmacol Exp Ther; 2006 Nov; 319(2):765-75. PubMed ID: 16882876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats.
    Yu XC; Wang HX; Zhang WM; Wong TM
    J Mol Cell Cardiol; 1999 Mar; 31(3):597-605. PubMed ID: 10198190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
    Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
    J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
    Zhang F; Li J; Li JG; Liu-Chen LY
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
    Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
    Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
    Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C.
    Bian JS; Wang HX; Zhang WM; Wong TM
    Br J Pharmacol; 1998 Jun; 124(3):600-6. PubMed ID: 9647487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
    Li JG; Chen C; Liu-Chen LY
    Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed uncoupling is related to cardioprotection induced by kappa-agonist U-50,488H in rat heart.
    Chen BP; Mao HJ; Fan FY; Bruce IC; Xia Q
    Scand Cardiovasc J; 2005 Dec; 39(6):375-82. PubMed ID: 16352491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
    Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats.
    Dziedzicka-Wasylewska M; Przewłocki R
    Pol J Pharmacol; 1995; 47(2):121-6. PubMed ID: 8688884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.